These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy. Schicho A; Pereira PL; Pützler M; Michalik K; Albrecht T; Nolte-Ernsting C; Stroszczynski C; Wiggermann P Med Sci Monit; 2017 Feb; 23():796-800. PubMed ID: 28192388 [TBL] [Abstract][Full Text] [Related]
10. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety. Liu D; Wang J; Ma Z; Zhang N; Zhao Y; Yang X; Wen Z; Xie H Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1092-1101. PubMed ID: 35588011 [TBL] [Abstract][Full Text] [Related]
11. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099 [TBL] [Abstract][Full Text] [Related]
12. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety. Zhang ZS; Li HZ; Ma C; Xiao YD BMC Cancer; 2019 Nov; 19(1):1162. PubMed ID: 31783814 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis. Yang XG; Sun YY; Li DS; Xu GH; Huang XQ Front Immunol; 2022; 13():940009. PubMed ID: 35874708 [TBL] [Abstract][Full Text] [Related]
15. Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma. Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Mulazzani L; Mattioli GM; Fiorentini G Anticancer Res; 2017 Apr; 37(4):1859-1863. PubMed ID: 28373452 [TBL] [Abstract][Full Text] [Related]
16. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study. Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984 [TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study. Jiang N; Zhang Z; Yin X; Qiu H; Yan W; Hao Y; Yang W; Li H; Xu A; Mu K Radiol Med; 2024 Apr; 129(4):631-642. PubMed ID: 38355907 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. Vogl TJ; Naguib NN; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T Eur Radiol; 2010 Jan; 20(1):173-80. PubMed ID: 19657653 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. Richardson AJ; Laurence JM; Lam VW J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916 [TBL] [Abstract][Full Text] [Related]
20. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study. Zhang X; Zhou J; Zhu DD; Huang J; Sun JH; Li TF; Shi CS; Sun ZC; Hou QM; Peng ZY; Yu WQ; Ji JS; Gu WJ; Zhou GH; Xie XX; Guo XH; Cao GH; Yu ZH; Xu HH; Fang J; Ying SH; Hu WH; Ji WB; Han J; Wu X; Zheng JP; Luo J; Chen YT; Hu TY; Li L; Hu HJ; Du HJ; Shao GL Clin Transl Oncol; 2019 Feb; 21(2):167-177. PubMed ID: 30003530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]